In Graves’ disease patients, an aberrant hypermethylation was observed for TRIM59, an aberrant hypomethylation for FHL2. In contrast, ELOVL2 and C1orf132 showed unchanged prediction accuracy in all disease groups. The gene discussed is ELOVL2; the disease is Graves disease.